Do Inflammation & Metabolic Disturbances Metastasize To The Brain? Implications For Disease Modeling & Novel Approaches In Psychiatry (Part 1 of 2)

Roger S. McIntyre, MD, FRCPC, is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. Dr. McIntyre is also Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada. His research is primarily aimed at characterizing the association between mood disorders, notably cognitive function and medical comorbidity. He was named by Thomson Reuters in 2014 and 2015, as one of “The World’s Most Influential Scientific Minds”.

Dr. McIntyre completed his medical degree at Dalhousie University.  He received his Psychiatry residency training and Fellowship in Psychiatric Pharmacology at the University of Toronto.

Rachel Thomas, MS, PharmD, serves as a Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc. Her clinical areas of expertise include: emergency medicine; acute agitation; inpatient pharmacy practice, and drug information.

Rachel attended the University of Mississippi in Oxford, Mississippi; the University of Alabama at Birmingham in Birmingham, Alabama; and the McWhorter School of Pharmacy in Birmingham, Alabama.